Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

NCT00006012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Drug/Agent Toxicity by Tissue/Organ
Lung Cancer
Radiation Toxicity

Interventions

BIOLOGICAL: filgrastim
DRUG: amifostine trihydrate
DRUG: cisplatin
DRUG: etoposide
DRUG: paclitaxel
DRUG: topotecan hydrochloride
RADIATION: radiation therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]